Clinical Trials

Showing 221 - 240 of 507 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of Rucaparib in Patients Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Relapsed/Refractory
[Protocol 13-255]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase II Study of Romidepsin after Autologous Stem Cell Transplantation in Patients with T-Cell Non-Hodgkin Lymphoma
[Protocol 13-020]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Response-Based Radiation Therapy for Patients with Localized Germ Cell Tumors of the Central Nervous System
[Protocol 12-243]
Dunkel, Ira
  • Germ Cell Tumors
  • Pediatric Brain Tumors
    • CNS Cancer
A Phase II Study of Regorafenib versus Placebo in Patients with Node-Positive Esophageal Cancer Who Completed Chemotherapy, Radiation Therapy, and Surgery
[Protocol 14-169]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study of Regorafenib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
[Protocol 13-244]
Ho, Alan
  • Head & Neck Cancer
A Phase II Study of Radioactive Iodine with and without Selumetinib in Patients with High-Risk Thyroid Cancer After Thyroidectomy
[Protocol 13-133]
Ho, Alan
  • Thyroid Cancer
A Phase II Study of RAD001 (Everolimus) and Pasireotide (SOM230)) in Patients with Advanced Uveal Melanoma
[Protocol 10-123]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of Preventive Radiation to the Brain with or without Radiation to Other Parts of the Body for Treating Small Cell Lung Cancer
Relapsed/Refractory
[Protocol 14-194]
Wu, Abraham
  • Lung Cancer, Small Cell
A Phase II Study of Pomalidomide plus Autologous Stem Cell Transplantation versus Pomalidomide/Dexamethasone in Patients with Multiple Myeloma
Relapsed/Refractory
[Protocol 12-138]
Giralt, Sergio
  • Hematology
    • Multiple Myeloma
A Phase II Study of Pimasertib with SAR245409 or a Placebo in Women with Previously Treated Inoperable Low-Grade Ovarian Cancer
[Protocol 13-173]
Grisham, Rachel
  • Ovarian Cancer
A Phase II Study of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
[Protocol 12-011]
Ilson, David
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study of Pegylated Interferon Alfa-2b (PEGIntron) in Children with Inoperable Craniopharyngioma After Prior Therapy
Relapsed/Refractory
[Protocol 14-037]
Khakoo, Yasmin
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of PCI-32765 in Patients with Relapsed and/or Refractory Multiple Myeloma
Relapsed/Refractory
[Protocol 12-055]
Lendvai, Nikoletta
  • Hematology
    • Multiple Myeloma
A Phase II Study of Palifermin with or without Leuprolide After T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-077]
Goldberg, Jenna
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Paclitaxel/Ifosfamide/Cisplatin versus Bleomycin/Etoposide/Cisplatin in Patients Newly Diagnosed with Advanced Germ Cell Tumors
[Protocol 13-074]
Feldman, Darren
  • Germ Cell Tumors
A Phase II Study of Paclitaxel/Carboplatin versus Bleomycin/Etoposide/Cisplatin for Patients with Advanced Ovarian Stromal Tumors Who Have Not Received Chemotherapy
Relapsed/Refractory
[Protocol 13-177]
Leitao, Mario
  • Ovarian Cancer
A Phase II Study of Nivolumab in Patients with Classical Hodgkin Lymphoma that Has Returned After Autologous Stem Cell Transplantation
[Protocol 14-147]
Younes, Anas
  • Lymphoma
    • Hodgkin's Disease
A Phase II Study of Nintedanib in Patients with Advanced Esophagogastric Cancer
[Protocol 14-094]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Neratinib to Treat Metastatic Breast Cancer that Does Not Overexpress HER2 but Has a HER2 Mutation
[Protocol 13-195]
Modi, Shanu
  • Breast Cancer
A Phase II Study of Neratinib in Patients with Solid Tumors Containing Mutated HER2
[Protocol 13-140]
Hyman, David
  • Bladder Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Solid Tumors
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
  • Uterine (Endometrial) Cancer